CME Group Inc. (NASDAQ:CME) Shares Purchased by Atomi Financial Group Inc.

Atomi Financial Group Inc. grew its position in shares of CME Group Inc. (NASDAQ:CME) by 12.0% during the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,746 shares of the financial services provider’s stock after purchasing an additional 187 shares during the period. Atomi Financial Group Inc.’s holdings in CME Group were worth $343,000 as of its most recent SEC filing.

Other large investors also recently added to or reduced their stakes in the company. Vanguard Group Inc. increased its stake in shares of CME Group by 0.6% during the fourth quarter. Vanguard Group Inc. now owns 33,451,194 shares of the financial services provider’s stock worth $7,044,821,000 after buying an additional 215,044 shares during the period. Capital International Investors lifted its stake in CME Group by 24.1% during the first quarter. Capital International Investors now owns 15,809,175 shares of the financial services provider’s stock worth $3,403,557,000 after purchasing an additional 3,069,806 shares during the last quarter. Capital World Investors increased its stake in CME Group by 8.7% in the fourth quarter. Capital World Investors now owns 14,589,867 shares of the financial services provider’s stock valued at $3,072,654,000 after purchasing an additional 1,172,575 shares during the last quarter. Bank of New York Mellon Corp raised its holdings in CME Group by 2.9% during the first quarter. Bank of New York Mellon Corp now owns 6,793,988 shares of the financial services provider’s stock worth $1,462,678,000 after purchasing an additional 189,842 shares in the last quarter. Finally, Parnassus Investments LLC lifted its position in shares of CME Group by 0.4% during the 4th quarter. Parnassus Investments LLC now owns 5,667,384 shares of the financial services provider’s stock worth $1,193,551,000 after buying an additional 23,583 shares during the last quarter. 87.75% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In related news, Director Charles P. Carey sold 3,000 shares of the company’s stock in a transaction on Thursday, June 13th. The stock was sold at an average price of $195.44, for a total transaction of $586,320.00. Following the completion of the transaction, the director now directly owns 7,163 shares in the company, valued at approximately $1,399,936.72. The sale was disclosed in a document filed with the SEC, which is available through this link. In related news, Director Daniel R. Glickman sold 650 shares of the stock in a transaction dated Thursday, June 6th. The shares were sold at an average price of $201.44, for a total value of $130,936.00. Following the completion of the transaction, the director now owns 14,008 shares in the company, valued at approximately $2,821,771.52. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Charles P. Carey sold 3,000 shares of the business’s stock in a transaction dated Thursday, June 13th. The stock was sold at an average price of $195.44, for a total transaction of $586,320.00. Following the completion of the sale, the director now owns 7,163 shares in the company, valued at $1,399,936.72. The disclosure for this sale can be found here. 0.30% of the stock is owned by company insiders.

Analysts Set New Price Targets

Several brokerages recently commented on CME. Piper Sandler reiterated an “overweight” rating and set a $225.00 price target on shares of CME Group in a research note on Tuesday, August 20th. JPMorgan Chase & Co. boosted their target price on CME Group from $187.00 to $191.00 and gave the company an “underweight” rating in a report on Thursday, July 25th. Barclays upped their target price on shares of CME Group from $208.00 to $209.00 and gave the company an “equal weight” rating in a report on Thursday, July 25th. Deutsche Bank Aktiengesellschaft upped their price objective on CME Group from $193.00 to $200.00 and gave the company a “hold” rating in a research note on Thursday, August 15th. Finally, Keefe, Bruyette & Woods boosted their target price on CME Group from $212.00 to $213.00 and gave the company a “market perform” rating in a report on Thursday, July 25th. Three investment analysts have rated the stock with a sell rating, six have issued a hold rating and three have assigned a buy rating to the company. According to data from MarketBeat, CME Group presently has a consensus rating of “Hold” and an average price target of $213.27.

CME Group Stock Performance

NASDAQ:CME traded up $3.32 during trading hours on Wednesday, reaching $215.72. 398,341 shares of the stock were exchanged, compared to its average volume of 1,912,176. The stock has a market capitalization of $77.67 billion, a P/E ratio of 24.16, a P/E/G ratio of 6.27 and a beta of 0.52. The firm has a 50 day simple moving average of $199.93 and a 200-day simple moving average of $207.22. The company has a quick ratio of 1.01, a current ratio of 1.02 and a debt-to-equity ratio of 0.10. CME Group Inc. has a 52 week low of $190.70 and a 52 week high of $223.80.

CME Group (NASDAQ:CME) last announced its quarterly earnings data on Wednesday, July 24th. The financial services provider reported $2.56 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.53 by $0.03. CME Group had a return on equity of 12.82% and a net margin of 56.98%. The firm had revenue of $1.53 billion for the quarter, compared to analysts’ expectations of $1.53 billion. During the same period last year, the business posted $2.30 earnings per share. The firm’s revenue for the quarter was up 12.7% on a year-over-year basis. As a group, sell-side analysts forecast that CME Group Inc. will post 9.8 earnings per share for the current fiscal year.

CME Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 25th. Investors of record on Monday, September 9th will be given a dividend of $1.15 per share. This represents a $4.60 dividend on an annualized basis and a dividend yield of 2.13%. The ex-dividend date is Monday, September 9th. CME Group’s dividend payout ratio is presently 52.33%.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.